J A Hirst
Overview
Explore the profile of J A Hirst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirst J, Farmer A, Williams V
Diabet Med
. 2019 Dec;
37(6):1008-1015.
PMID: 31876039
Aim: To explore adults with diabetes and clinician views of point-of-care HbA testing. Methods: Adults with diabetes and HbA ≥ 58 mmol/mol (7.5%) receiving HbA point-of-care testing in primary care...
2.
Hirst J, Farmer A, Smith M, Stevens R
Diabet Med
. 2018 Sep;
36(1):36-43.
PMID: 30175871
Aims: Guidelines recommend testing HbA every 3-6 months in people with diabetes. In the United Kingdom (UK), primary care clinics are financially incentivized to monitor HbA at least annually and...
3.
Hirst J, Stevens R, Smith I, James T, Gudgin B, Farmer A
Diabetes Res Clin Pract
. 2017 Jun;
130:113-120.
PMID: 28602811
Aims: Point-of-care (POC) HbA1c testing gives a rapid result, allowing testing and treatment decisions to take place in a single appointment. Trials of POC testing have not been shown to...
4.
Hirst J, Aronson J, Feakins B, Ma C, Farmer A, Stevens R
Diabet Med
. 2016 Sep;
34(5):604-611.
PMID: 27588354
Background: People with diabetes are told that drinking alcohol may increase their risk of hypoglycaemia. Aims: To report the effects of alcohol consumption on glycaemic control in people with diabetes...
5.
Hirst J, Farmer A, Dyar A, Lung T, Stevens R
Diabetologia
. 2013 Mar;
56(5):973-84.
PMID: 23494446
Aims/hypothesis: Sulfonylureas are widely prescribed glucose-lowering medications for diabetes, but the extent to which they improve glycaemia is poorly documented. This systematic review evaluates how sulfonylurea treatment affects glycaemic control....
6.
Stevens R, Ali R, Bankhead C, Bethel M, Cairns B, Camisasca R, et al.
Diabetologia
. 2012 Aug;
55(10):2593-2603.
PMID: 22875195
Aims/hypothesis: Observational studies suggest that metformin may reduce cancer risk by approximately one-third. We examined cancer outcomes and all-cause mortality in published randomised controlled trials (RCTs). Methods: RCTs comparing metformin...
7.
Blacklock C, Hirst J, Taylor K, Stevens R, Roberts N, Farmer A
Diabet Med
. 2011 Jun;
28(10):1182-7.
PMID: 21627686
Aims: Renin-angiotensin inhibitors in Type 2 diabetes and microalbuminuria reduce renal and cardiovascular risk, but evidence supporting use of maximal tolerated dose is unclear. We aimed to determine the extent...
8.
Azar R, Waters D, McKay R, Giri S, Hirst J, Mitchell J, et al.
Am J Cardiol
. 2002 May;
85(6):675-9.
PMID: 12000039
Women presenting with acute myocardial infarction (AMI) have a higher mortality with conventional medical and thrombolytic therapy when compared with men. The outcome after primary percutaneous transluminal mechanical revascularization has...
9.
Giri S, Mitchel J, Hirst J, McKay R, Azar R, Mennett R, et al.
Am J Cardiol
. 2000 Aug;
86(3):269-74.
PMID: 10922431
This study examined 650 consecutive patients who presented with an acute myocardial infarction and were treated with primary angioplasty within 12 hours of symptom onset between August 1995 and December...
10.
Giri S, Thompson P, Kiernan F, Clive J, Fram D, Mitchel J, et al.
JAMA
. 1999 Nov;
282(18):1731-6.
PMID: 10568645
Context: Vigorous physical exertion transiently increases the risk of acute myocardial infarction (MI), but little is known about the clinical characteristics of exertion-related MI. Objective: To compare the clinical and...